Alcon Completes Availability of Clareon Portfolio with Clareon Toric During AAO 2022 - Seite 2

The need for remote, digital solutions in ophthalmology has never been greater, given worldwide surgery backlogs and staffing shortages. Alcon is committed to shaping digital transformation in ophthalmology. In addition to the opportunity to demo Fidelis, surgeons will be able to experience and sign up for a resource that educates cataract patients about surgery and advanced technology IOL options via SMS text. These activities will take place at Alcon booth #3926 at the AAO exhibit hall, on Oct. 1-3 from 9:00 a.m.–5:00 p.m. Central Time.

Data highlight benefits of Alcon surgical ophthalmic products
Key studies being presented on Alcon products include:

• Global registry data in more than 750 patients surrounding AcrySof IQ Vivity IOL supports continued patient satisfaction, low instances of visual disturbances and reduced spectacle dependence.¹³
• Results from a multicenter, prospective clinical trial demonstrates energy and surgical time savings when using the CENTURION phacoemulsification system with Active Sentry.¹⁴
• A novel retina imaging technique using the NGENUITY 3D Visualization System unveiled by surgeons seeking to develop more efficient methods for fluorescein angiography.¹⁵
• A clinical study of 500 eyes comparing results of CONTOURA Laser Vision Correction with Phorcides Analytic Engine in low versus high myopia.¹⁶

To learn more about Alcon news, events and data taking place during AAO, please visit MyAlconatAAO.com.

About Clareon IOLs and Delivery Systems
The family of Clareon intraocular lenses (IOLs) includes the Clareon Aspheric Hydrophobic Acrylic and Clareon Aspheric Toric IOLs, the Clareon PanOptix Trifocal Hydrophobic IOL, Clareon PanOptix Toric, Clareon Vivity Extended Vision Hydrophobic Posterior Chamber IOL and Clareon Vivity Toric IOLs. Each of these IOLs is indicated for visual correction of aphakia in adult patients following cataract surgery. In addition, the Clareon Toric IOLs are indicated to correct pre-existing corneal astigmatism at the time of cataract surgery. The Clareon PanOptix lens mitigates the effects of presbyopia by providing improved intermediate and near visual acuity while maintaining comparable distance visual acuity with a reduced need for eyeglasses, compared to a monofocal IOL. The Clareon Vivity lens mitigates the effects of presbyopia by providing an extended depth of focus. Compared to an aspheric monofocal IOL, the lens provides improved intermediate and near visual acuity while maintaining comparable distance visual acuity. All of these IOLs are intended for placement in the capsular bag. Careful preoperative evaluation and sound clinical judgment should be used by the surgeon to decide the risk/benefit ratio before implanting any IOL in a patient with any of the conditions described in the Directions for Use that accompany each IOL. Prior to surgery, physicians should provide prospective patients with a copy of the Patient Information Brochure available from Alcon, informing them of possible risks and benefits associated with these IOLs. Reference the Directions for Use labelling for each IOL for a complete listing of indications, warnings and precautions.